ATE401075T1 - Cytisinehaltiges arzneimittel - Google Patents
Cytisinehaltiges arzneimittelInfo
- Publication number
- ATE401075T1 ATE401075T1 AT05472001T AT05472001T ATE401075T1 AT E401075 T1 ATE401075 T1 AT E401075T1 AT 05472001 T AT05472001 T AT 05472001T AT 05472001 T AT05472001 T AT 05472001T AT E401075 T1 ATE401075 T1 AT E401075T1
- Authority
- AT
- Austria
- Prior art keywords
- cytisine
- product containing
- medicinal product
- tablets
- containing cytisine
- Prior art date
Links
- ANJTVLIZGCUXLD-BDAKNGLRSA-N (-)-Cytisine Natural products C1NC[C@@H]2CN3C(=O)C=CC=C3[C@H]1C2 ANJTVLIZGCUXLD-BDAKNGLRSA-N 0.000 title abstract 4
- ANJTVLIZGCUXLD-DTWKUNHWSA-N cytisine Chemical compound C1NC[C@H]2CN3C(=O)C=CC=C3[C@@H]1C2 ANJTVLIZGCUXLD-DTWKUNHWSA-N 0.000 title abstract 4
- 229940027564 cytisine Drugs 0.000 title abstract 4
- 229930017327 cytisine Natural products 0.000 title abstract 4
- ANJTVLIZGCUXLD-UHFFFAOYSA-N ent-cytisine Natural products C1NCC2CN3C(=O)C=CC=C3C1C2 ANJTVLIZGCUXLD-UHFFFAOYSA-N 0.000 title abstract 4
- 229940126601 medicinal product Drugs 0.000 title 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000013081 microcrystal Substances 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG108686A BG65536B1 (bg) | 2004-04-16 | 2004-04-16 | Лекарствена форма, съдържаща цитизин |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401075T1 true ATE401075T1 (de) | 2008-08-15 |
Family
ID=34943361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05472001T ATE401075T1 (de) | 2004-04-16 | 2005-02-02 | Cytisinehaltiges arzneimittel |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1586320B1 (de) |
| AT (1) | ATE401075T1 (de) |
| BG (1) | BG65536B1 (de) |
| DE (1) | DE602005008128D1 (de) |
| PL (1) | PL1586320T3 (de) |
| SI (1) | SI1586320T1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL220354B1 (pl) | 2012-11-19 | 2015-10-30 | Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością | Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania |
| CN103284319A (zh) * | 2013-06-20 | 2013-09-11 | 昌宁德康生物科技有限公司 | 一种金雀花碱替代尼古丁口腔雾化液及其制备方法 |
| PL408608A1 (pl) | 2014-06-18 | 2015-12-21 | Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością | Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania |
| GB201602145D0 (en) | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
| HRP20221497T1 (hr) | 2016-08-19 | 2023-02-17 | The University Of Bristol | Derivati citizina za liječenje ovisnosti |
| KR102688861B1 (ko) * | 2017-07-24 | 2024-07-25 | 어치브 파마 유케이 리미티드 | 시티신 염 |
| EP3598968A1 (de) | 2018-07-23 | 2020-01-29 | Adamed Pharma S.A. | Feste pharmazeutische cytisin-zusammensetzung |
| BG67408B1 (bg) * | 2019-04-12 | 2022-01-17 | Софарма Ад | Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1178045B1 (de) * | 1997-04-09 | 2003-05-28 | Pfizer Inc. | Azindolethylaminderivate als Nikotin-acetylcholin-Rezeptor Bindung Verbindungen |
| US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
-
2004
- 2004-04-16 BG BG108686A patent/BG65536B1/bg unknown
-
2005
- 2005-02-02 AT AT05472001T patent/ATE401075T1/de not_active IP Right Cessation
- 2005-02-02 DE DE602005008128T patent/DE602005008128D1/de not_active Expired - Lifetime
- 2005-02-02 SI SI200530386T patent/SI1586320T1/sl unknown
- 2005-02-02 PL PL05472001T patent/PL1586320T3/pl unknown
- 2005-02-02 EP EP05472001A patent/EP1586320B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SI1586320T1 (sl) | 2009-02-28 |
| PL1586320T3 (pl) | 2008-12-31 |
| EP1586320A1 (de) | 2005-10-19 |
| BG108686A (en) | 2005-12-30 |
| EP1586320B1 (de) | 2008-07-16 |
| BG65536B1 (bg) | 2008-11-28 |
| DE602005008128D1 (de) | 2008-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
| UA108594C2 (uk) | Одинична дозована фармацевтична форма | |
| EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
| WO2003066029A3 (en) | Pharmaceutical dosage form for mucosal delivery | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| MY127350A (en) | Flash-melt oral dose formulations | |
| IL150528A0 (en) | Ibuprofen containing active agent preparation | |
| ATE488225T1 (de) | Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff | |
| MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
| ATE401075T1 (de) | Cytisinehaltiges arzneimittel | |
| WO2008079343A3 (en) | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients | |
| BR0308305A (pt) | Fórmulas dosadas de liberação controlada | |
| MXPA06010146A (es) | Formas de dosificacion solidas biodisponibles de metaxalona. | |
| WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
| HUP0203148A2 (hu) | Mirtazapint tartalmazó orálisan dezintegrálódó készítmény | |
| WO2007120838A3 (en) | Rapidly disintegrating solid oral dosage form of liquid dispersions | |
| MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
| ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
| WO2003013441A3 (en) | Levothyroxine compositions and methods | |
| WO2004014318A3 (en) | Levothyroxine compositions and methods | |
| ATE311183T1 (de) | Enalaprilmaleat enthaltende, stabile, feste arzneimittel | |
| WO2002045618A3 (de) | Schluck-kapsel zur tabletten-einnahme bei tieren | |
| PL1499278T3 (pl) | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |